{"id": "1369417714004033548", "creation": 1615329600.0, "user_id": "18026170", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 0, "reply_count": 0, "like_count": 1, "quote_count": 0}}, "text": ".@GreenLightBio1 &amp; @TFFPharma to study feasibility of shelf-stable #formulation of #COVID19 #mRNA #vaccine\n\nLook to develop dry powder format that is easily reconstituted &amp; does not require #ColdChain\n\nhttps://t.co/ntkPijzQtB\n#InfectiousDiseases #SARSCoV2 @LaVoieGroup https://t.co/4FHeqF03BL", "first_save": 1634559108.199414, "hashtags": ["#FORMULATION", "#COVID19", "#MRNA", "#VACCINE", "#COLDCHAIN", "#INFECTIOUSDISEASES", "#SARSCOV2"]}